Literature DB >> 8642316

Tracing the development of single memory-lineage B cells in a highly defined immune response.

A H Liu1, P K Jena, L J Wysocki.   

Abstract

To study the development of B lymphocyte memory, we identified and isolated splenic B cells expressing a highly defined antibody variable region that constitutes a reproducible and predominant component of the memory antibody response to p-azophenylarsonate (Ars). Isolation was achieved during the primary immune response by surface staining and flow cytometry using a specific anti-idiotypic antibody called E4, which recognizes this canonical V region, encoded by one set of V gene segments. The isolated E4+ cells displayed all of the phenotypic characteristics of germinal center centrocytes, including a low level of surface Ig, a lack of surface IgD, a high level of receptor for peanut agglutinin, and expression of mutated antibody V genes. E4+ B cells were first detected in the spleen 7-8 d after primary immunization, reached peak numbers from days 10-13, and waned by day 16. Surprisingly, at their peak, E4+ cells comprised only 40,000 of all splenocytes, and half of these failed to bind Ars. Using this number, we estimate the total number of Ars-specific memory-lineage cells in the spleen to be no more than 50,000 (0.1%) at any one time, and presumably far fewer that are committed to the memory pool. Chromosomal copies of rearranged V genes from single E4+ cells were amplified by nested PCR, and the amplified products were sequenced directly without cloning, using standardized conditions that disclose virtually no Taq polymerase errors. V gene sequence analyses of E4+ cells isolated from single mice confirmed their canonical nature and revealed that they were derived from few precursors. In the average mouse, the E4+ pool was derived from fewer than five canonical precursors. Somatic mutations were found within the V genes of almost all cell isolates. At day 13, a significant fraction of E4+ cells had mutations known to increase antibody affinity for Ars, suggesting they were products of at least one cycle of post-mutational antigen-driven selection. However, the lack of shared mutations by clonally related cells indicated that the selective expansion of mutant subclones typical of memory responses had not yet taken place. This was supported by the observation that half of the E4+ cells failed to bind Ars. Collectively, our results indicate that the memory compartment is a highly selected entity, even at relatively early stages of the primary immune response when somatic mutation and clonal selection are still in progress. If germinal centers are the source of memory B cells, our data suggest that B cell memory may be derived from only a small fraction of all germinal centers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642316      PMCID: PMC2192589          DOI: 10.1084/jem.183.5.2053

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  55 in total

1.  V kappa and J kappa gene segments of A/J Ars-A antibodies: somatic recombination generates the essential arginine at the junction of the variable and joining regions.

Authors:  I Sanz; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

2.  Site-directed mutagenesis of an invariant amino acid residue at the variable-diversity segments junction of an antibody.

Authors:  J Sharon; M L Gefter; T Manser; M Ptashne
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

3.  Somatic evolution of variable region structures during an immune response.

Authors:  L Wysocki; T Manser; M L Gefter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

Review 4.  Evolution of antibody variable region structure during the immune response.

Authors:  T Manser; L J Wysocki; M N Margolies; M L Gefter
Journal:  Immunol Rev       Date:  1987-04       Impact factor: 12.988

5.  Memory B lymphocytes in human tonsil do not express surface IgD.

Authors:  I C Nicholson; M J Brisco; H Zola
Journal:  J Immunol       Date:  1995-02-01       Impact factor: 5.422

6.  Germ-line sequence of the DH segment employed in Ars-A antibodies: implications for the generation of junctional diversity.

Authors:  N F Landolfi; J D Capra; P W Tucker
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

7.  Somatic evolution of diversity among anti-phosphocholine antibodies induced with Proteus morganii.

Authors:  J L Claflin; J Berry; D Flaherty; W Dunnick
Journal:  J Immunol       Date:  1987-05-01       Impact factor: 5.422

8.  The molecular evolution of the immune response: idiotope-specific suppression indicates that B cells express germ-line-encoded V genes prior to antigenic stimulation.

Authors:  T Manser; M L Gefter
Journal:  Eur J Immunol       Date:  1986-11       Impact factor: 5.532

9.  Influence of clonal selection on the expression of immunoglobulin variable region genes.

Authors:  T Manser; S Y Huang; M L Gefter
Journal:  Science       Date:  1984-12-14       Impact factor: 47.728

10.  Inter- and intraclonal diversity in the antibody response to influenza hemagglutinin.

Authors:  S H Clarke; K Huppi; D Ruezinsky; L Staudt; W Gerhard; M Weigert
Journal:  J Exp Med       Date:  1985-04-01       Impact factor: 14.307

View more
  12 in total

1.  Complete analysis of the B-cell response to a protein antigen, from in vivo germinal centre formation to 3-D modelling of affinity maturation.

Authors:  Claire L Adams; Megan K L Macleod; E James Milner-White; Robert Aitken; Paul Garside; David I Stott
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

2.  Silent development of memory progenitor B cells.

Authors:  Katja Aviszus; Xianghua Zhang; Lawrence J Wysocki
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

3.  Epitope-specific human influenza antibody repertoires diversify by B cell intraclonal sequence divergence and interclonal convergence.

Authors:  Jens C Krause; Tshidi Tsibane; Terrence M Tumpey; Chelsey J Huffman; Bryan S Briney; Scott A Smith; Christopher F Basler; James E Crowe
Journal:  J Immunol       Date:  2011-08-31       Impact factor: 5.422

Review 4.  The role of germinal centers for antiviral B cell responses.

Authors:  M F Bachmann
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

5.  The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary immune response.

Authors:  K G Smith; A Light; G J Nossal; D M Tarlinton
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

6.  Memory B cells in common variable immunodeficiency: clinical associations and sex differences.

Authors:  Silvia Sánchez-Ramón; Lin Radigan; Joyce E Yu; Susan Bard; Charlotte Cunningham-Rundles
Journal:  Clin Immunol       Date:  2008-07-11       Impact factor: 3.969

7.  Taking advantage: high-affinity B cells in the germinal center have lower death rates, but similar rates of division, compared to low-affinity cells.

Authors:  Shannon M Anderson; Ashraf Khalil; Mohamed Uduman; Uri Hershberg; Yoram Louzoun; Ann M Haberman; Steven H Kleinstein; Mark J Shlomchik
Journal:  J Immunol       Date:  2009-11-16       Impact factor: 5.422

8.  Antigen-specific B cell memory: expression and replenishment of a novel b220(-) memory b cell compartment.

Authors:  L J McHeyzer-Williams; M Cool; M G McHeyzer-Williams
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

9.  Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells.

Authors:  Götz R A Ehrhardt; Joyce T Hsu; Lanier Gartland; Chuen-Miin Leu; Shuangyin Zhang; Randall S Davis; Max D Cooper
Journal:  J Exp Med       Date:  2005-09-12       Impact factor: 14.307

10.  New markers for murine memory B cells that define mutated and unmutated subsets.

Authors:  Shannon M Anderson; Mary M Tomayko; Anupama Ahuja; Ann M Haberman; Mark J Shlomchik
Journal:  J Exp Med       Date:  2007-08-13       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.